Selected research
Industry Research
Daptomycin Industry Research Report 2026
Market perspective
The global Daptomycin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Daptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Daptomycin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Daptomycin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Daptomycin include HENGRUI PHARMA, Hisun, Sagent Pharmaceuticals, Xellia, Fresenius Kabi, Huadong Medicine, Pfizer, Mylan and Merck & Co., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Daptomycin market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Daptomycin Market by Company
HENGRUI PHARMA
Hisun
Sagent Pharmaceuticals
Xellia
Fresenius Kabi
Huadong Medicine
Pfizer
Mylan
Merck & Co.
Teva
Daptomycin Segment by Type
350 mg Lyophilized Powder
500 mg Lyophilized Powder
Daptomycin Segment by Application
Adult
Pediatric Patients (1 to 17 years of age)
Daptomycin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Daptomycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Daptomycin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Daptomycin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Daptomycin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Daptomycin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Daptomycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 350 mg Lyophilized Powder
- 500 mg Lyophilized Powder
Applications
- Adult
- Pediatric Patients (1 to 17 years of age)
Companies covered
- HENGRUI PHARMA
- Hisun
- Sagent Pharmaceuticals
- Xellia
- Fresenius Kabi
- Huadong Medicine
- Pfizer
- Mylan
- Merck & Co.
- Teva
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Daptomycin Market Size (2021-2032)
- 2.2.2 Global Daptomycin Sales (2021-2032)
- 2.2.3 Global Daptomycin Market Average Price (2021-2032)
- 2.3 Daptomycin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 350 mg Lyophilized Powder
- 2.3.3 500 mg Lyophilized Powder
- 2.4 Daptomycin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult
- 2.4.3 Pediatric Patients (1 to 17 years of age)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Daptomycin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Daptomycin Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Daptomycin Revenue of Manufacturers (2021-2026)
- 3.4 Global Daptomycin Average Price by Manufacturers (2021-2026)
- 3.5 Global Daptomycin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Daptomycin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Daptomycin, Product Type & Application
- 3.8 Global Manufacturers of Daptomycin, Established Date
- 3.9 Global Daptomycin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 HENGRUI PHARMA
- 4.1.1 HENGRUI PHARMA Company Information
- 4.1.2 HENGRUI PHARMA Business Overview
- 4.1.3 HENGRUI PHARMA Daptomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 HENGRUI PHARMA Daptomycin Product Portfolio
- 4.1.5 HENGRUI PHARMA Recent Developments
- 4.2 Hisun
- 4.2.1 Hisun Company Information
- 4.2.2 Hisun Business Overview
- 4.2.3 Hisun Daptomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hisun Daptomycin Product Portfolio
- 4.2.5 Hisun Recent Developments
- 4.3 Sagent Pharmaceuticals
- 4.3.1 Sagent Pharmaceuticals Company Information
- 4.3.2 Sagent Pharmaceuticals Business Overview
- 4.3.3 Sagent Pharmaceuticals Daptomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sagent Pharmaceuticals Daptomycin Product Portfolio
- 4.3.5 Sagent Pharmaceuticals Recent Developments
- 4.4 Xellia
- 4.4.1 Xellia Company Information
- 4.4.2 Xellia Business Overview
- 4.4.3 Xellia Daptomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Xellia Daptomycin Product Portfolio
- 4.4.5 Xellia Recent Developments
- 4.5 Fresenius Kabi
- 4.5.1 Fresenius Kabi Company Information
- 4.5.2 Fresenius Kabi Business Overview
- 4.5.3 Fresenius Kabi Daptomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Fresenius Kabi Daptomycin Product Portfolio
- 4.5.5 Fresenius Kabi Recent Developments
- 4.6 Huadong Medicine
- 4.6.1 Huadong Medicine Company Information
- 4.6.2 Huadong Medicine Business Overview
- 4.6.3 Huadong Medicine Daptomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Huadong Medicine Daptomycin Product Portfolio
- 4.6.5 Huadong Medicine Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Daptomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Daptomycin Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Mylan
- 4.8.1 Mylan Company Information
- 4.8.2 Mylan Business Overview
- 4.8.3 Mylan Daptomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mylan Daptomycin Product Portfolio
- 4.8.5 Mylan Recent Developments
- 4.9 Merck & Co.
- 4.9.1 Merck & Co. Company Information
- 4.9.2 Merck & Co. Business Overview
- 4.9.3 Merck & Co. Daptomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Merck & Co. Daptomycin Product Portfolio
- 4.9.5 Merck & Co. Recent Developments
- 4.10 Teva
- 4.10.1 Teva Company Information
- 4.10.2 Teva Business Overview
- 4.10.3 Teva Daptomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Teva Daptomycin Product Portfolio
- 4.10.5 Teva Recent Developments
5 Global Daptomycin Market Scenario by Region
- 5.1 Global Daptomycin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Daptomycin Sales by Region: 2021-2032
- 5.2.1 Global Daptomycin Sales by Region: 2021-2026
- 5.2.2 Global Daptomycin Sales by Region: 2027-2032
- 5.3 Global Daptomycin Revenue by Region: 2021-2032
- 5.3.1 Global Daptomycin Revenue by Region: 2021-2026
- 5.3.2 Global Daptomycin Revenue by Region: 2027-2032
- 5.4 North America Daptomycin Market Facts & Figures by Country
- 5.4.1 North America Daptomycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Daptomycin Sales by Country (2021-2032)
- 5.4.3 North America Daptomycin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Daptomycin Market Facts & Figures by Country
- 5.5.1 Europe Daptomycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Daptomycin Sales by Country (2021-2032)
- 5.5.3 Europe Daptomycin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Daptomycin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Daptomycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Daptomycin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Daptomycin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Daptomycin Market Facts & Figures by Country
- 5.7.1 South America Daptomycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Daptomycin Sales by Country (2021-2032)
- 5.7.3 South America Daptomycin Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Daptomycin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Daptomycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Daptomycin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Daptomycin Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Daptomycin Sales by Type (2021-2032)
- 6.1.1 Global Daptomycin Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Daptomycin Sales Market Share by Type (2021-2032)
- 6.2 Global Daptomycin Revenue by Type (2021-2032)
- 6.2.1 Global Daptomycin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Daptomycin Revenue Market Share by Type (2021-2032)
- 6.3 Global Daptomycin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Daptomycin Sales by Application (2021-2032)
- 7.1.1 Global Daptomycin Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Daptomycin Sales Market Share by Application (2021-2032)
- 7.2 Global Daptomycin Revenue by Application (2021-2032)
- 7.2.1 Global Daptomycin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Daptomycin Revenue Market Share by Application (2021-2032)
- 7.3 Global Daptomycin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Daptomycin Value Chain Analysis
- 8.1.1 Daptomycin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Daptomycin Production Mode & Process
- 8.2 Daptomycin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Daptomycin Distributors
- 8.2.3 Daptomycin Customers
9 Global Daptomycin Analyzing Market Dynamics
- 9.1 Daptomycin Industry Trends
- 9.2 Daptomycin Industry Drivers
- 9.3 Daptomycin Industry Opportunities and Challenges
- 9.4 Daptomycin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst